ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Yaldigo 400 mg, magensaftresistente Tablette - 100
53108004 Tillotts Pharma AG
Yaldigo 400 mg, magensaftresistente Tablette15.11.1994
  15.11.1994
Mesalazine (A07EC02)12.03.2004
WHO-DDD 
04.09.100
04.09. 
B  
No 
IPCI
PR  
k.A.PR
  
7680531080042Synthetika
  
Composition
mesalazinum 400 mg, lactosum monohydricum 76.4 mg, carboxymethylamylum natricum A corresp. natrium 0.768 mg, magnesii stearas, talcum, povidonum K 25, Überzug: acidi methacrylici et methylis methacrylatis polymerisatum 1:2, talcum, triethylis citras, macrogolum 6000, E 172, pro compresso obducto.
Packungsbestandteile
Gastric juice resistant tablets
 
Active AgentDose
Mesalazine400 mg
 
Inactive agentsDoseadditional_information
Acidi Methacrylici Überzug
Carboxymethylamylum Natricum A  
E 172 color.
Lactose Monohydrate76.4 mg 
Macrogol6000  
Magnesii Stearas  
Methylis Methacrylatis Polymerisatum  
Povidonum K25  
Pro Compresso Obducto  
Talcum  
Triethylis Citras  
Source
Data was imported : 06.12.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home